APO Research
Talk to an analyst

APO RESEARCH · REPORT

Whole Exome Sequencing

Exome sequencing is a capture based method developed to identify variants in the coding region of genes which affect protein function. While exome capture methods using PCR, hybrid capture and molecular inversion probes exist, the most common and efficient strategies are in-solution capture methods. In-solution capture utilizes pools of oligonucleotides or probes bound to magnetic beads, whose sequence has been designed to hybridize to exon regions. After binding to genomic DNA, these probes are pulled down and washed, allowing exon regions to be selectively sequenced.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Exome sequencing is a capture based method developed to identify variants in the coding region of genes which affect protein function. While exome capture methods using PCR, hybrid capture and molecular inversion probes exist, the most common and efficient strategies are in-solution capture methods. In-solution capture utilizes pools of oligonucleotides or probes bound to magnetic beads, whose sequence has been designed to hybridize to exon regions. After binding to genomic DNA, these probes are pulled down and washed, allowing exon regions to be selectively sequenced.

While there are approximately 180,000 exons in the human genome, constituting less than 2% of total sequence, the exome contains ~80-90% of known disease causing variants making it a cost-effective alternative to whole genome sequencing. When performing exome-seq, users should not only consider average on-target coverage but also the local coverage of particular sites of interest. When choosing between exome and whole genome sequencing (WGS), consider that exome sequencing has the advantage that oligonucleotides are designed to particular genomic regions where typical coverage with WGS is not enough for SNP calling. It is also more affordable enabling the analysis of more individuals and populations. With WGS, you can detect variants in regions not covered by exome capture allowing or the identification of structural and non-coding variants associated with disease.

Selected research

Market Analysis & Forecast

Global Whole Exome Sequencing Market Analysis and Forecast 2026-2032

2 January 2026191 pages

Choose your research edition.

Industry ResearchWhole Exome Sequencing Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Whole Exome Sequencing Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Whole Exome Sequencing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Whole Exome Sequencing Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Whole Exome Sequencing Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Exome sequencing is a capture based method developed to identify variants in the coding region of genes which affect protein function. While exome capture methods using PCR, hybrid capture and molecular inversion probes exist, the most common and efficient strategies are in-solution capture methods. In-solution capture utilizes pools of oligonucleotides or probes bound to magnetic beads, whose sequence has been designed to hybridize to exon regions. After binding to genomic DNA, these probes are pulled down and washed, allowing exon regions to be selectively sequenced.

While there are approximately 180,000 exons in the human genome, constituting less than 2% of total sequence, the exome contains ~80-90% of known disease causing variants making it a cost-effective alternative to whole genome sequencing. When performing exome-seq, users should not only consider average on-target coverage but also the local coverage of particular sites of interest. When choosing between exome and whole genome sequencing (WGS), consider that exome sequencing has the advantage that oligonucleotides are designed to particular genomic regions where typical coverage with WGS is not enough for SNP calling. It is also more affordable enabling the analysis of more individuals and populations. With WGS, you can detect variants in regions not covered by exome capture allowing or the identification of structural and non-coding variants associated with disease.

The major players in global Whole Exome Sequencing market include Illumina, Thermofisher, Roche, etc. The top 3 players occupy about 45% shares of the global market. North America and Europe are main markets, they occupy about 70% of the global market. Illumina TruSeq Exome and Roche Nimblegen SeqCap are main types, with a share about 55%. Mendelian Disease and Rare Syndrome Gene Discovery are the main application, which hold a share about 40%.

Read the full market overview

Report Includes

This report presents an overview of global market for Whole Exome Sequencing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Whole Exome Sequencing, also provides the revenue of main regions and countries. Of the upcoming market potential for Whole Exome Sequencing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Whole Exome Sequencing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Whole Exome Sequencing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Whole Exome Sequencing revenue, projected growth trends, production technology, application and end-user industry.

Whole Exome Sequencing Segment by Company

Illumina

Thermo Fisher

Roche

Angilent

Eurofins

Sengenics

Ambry

Macrogen

BGI

Novo Gene

Whole Exome Sequencing Segment by Type

Agilent HaloPlex

Agilent SureSelect

Agilent SureSelect QXT

Illumina TruSeq Exome

Roche Nimblegen SeqCap

MYcroarray MYbaits

Whole Exome Sequencing Segment by Application

Correlation Research of Normal Human

Mendelian Disease and Rare Syndrome Gene Discovery

The Research of Complex Diseases

Mouse Exome Sequencing

Whole Exome Sequencing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Whole Exome Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Whole Exome Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Whole Exome Sequencing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Whole Exome Sequencing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Whole Exome Sequencing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Whole Exome Sequencing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Whole Exome Sequencing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Agilent HaloPlex Major Player Table 3. Agilent SureSelect Major Player Table 4. Agilent SureSelect QXT Major Player Table 5. Illumina TruSeq Exome Major Player Table 6. Roche Nimblegen SeqCap Major Player Table 7. MYcroarray MYbaits Major Player Table 8. Global Whole Exome Sequencing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Correlation Research of Normal Human Major Player Table 10. Mendelian Disease and Rare Syndrome Gene Discovery Major Player Table 11. The Research of Complex Diseases Major Player Table 12. Mouse Exome Sequencing Major Player Table 13. Whole Exome Sequencing Industry Trends Table 14. Whole Exome Sequencing Industry Drivers Table 15. Whole Exome Sequencing Industry Opportunities and Challenges Table 16. Whole Exome Sequencing Industry Restraints Table 17. Global Whole Exome Sequencing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 18. Global Whole Exome Sequencing Market Size by Region (2021-2026) & (US$ Million) Table 19. Global Whole Exome Sequencing Market Share by Region (2021-2026) Table 20. Global Whole Exome Sequencing Market Size by Region (2027-2032) & (US$ Million) Table 21. Global Whole Exome Sequencing Market Share by Region (2027-2032) Table 22. Global Whole Exome Sequencing Revenue by Players (US$ Million) & (2021-2026) Table 23. Global Whole Exome Sequencing Revenue Market Share by Players (2021-2026) Table 24. Global Whole Exome Sequencing Key Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Whole Exome Sequencing Key Players Headquarters & Area Served Table 26. Global Whole Exome Sequencing Players, Product Type & Application Table 27. Global Whole Exome Sequencing Players Establishment Date Table 28. Global Players Market Concentration Ratio (CR5 and HHI) Table 29. Global Whole Exome Sequencing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 30. Global Whole Exome Sequencing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Whole Exome Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 32. Global Whole Exome Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 33. Global Whole Exome Sequencing Revenue Market Share by Type (2021-2026) Table 34. Global Whole Exome Sequencing Revenue Market Share by Type (2027-2032) Table 35. Global Whole Exome Sequencing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Whole Exome Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 37. Global Whole Exome Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 38. Global Whole Exome Sequencing Revenue Market Share by Application (2021-2026) Table 39. Global Whole Exome Sequencing Revenue Market Share by Application (2027-2032) Table 40. Illumina Company Information Table 41. Illumina Business Overview Table 42. Illumina Whole Exome Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Illumina Whole Exome Sequencing Product Portfolio Table 44. Illumina Recent Development Table 45. Thermo Fisher Company Information Table 46. Thermo Fisher Business Overview Table 47. Thermo Fisher Whole Exome Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Thermo Fisher Whole Exome Sequencing Product Portfolio Table 49. Thermo Fisher Recent Development Table 50. Roche Company Information Table 51. Roche Business Overview Table 52. Roche Whole Exome Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Roche Whole Exome Sequencing Product Portfolio Table 54. Roche Recent Development Table 55. Angilent Company Information Table 56. Angilent Business Overview Table 57. Angilent Whole Exome Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Angilent Whole Exome Sequencing Product Portfolio Table 59. Angilent Recent Development Table 60. Eurofins Company Information Table 61. Eurofins Business Overview Table 62. Eurofins Whole Exome Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Eurofins Whole Exome Sequencing Product Portfolio Table 64. Eurofins Recent Development Table 65. Sengenics Company Information Table 66. Sengenics Business Overview Table 67. Sengenics Whole Exome Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Sengenics Whole Exome Sequencing Product Portfolio Table 69. Sengenics Recent Development Table 70. Ambry Company Information Table 71. Ambry Business Overview Table 72. Ambry Whole Exome Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Ambry Whole Exome Sequencing Product Portfolio Table 74. Ambry Recent Development Table 75. Macrogen Company Information Table 76. Macrogen Business Overview Table 77. Macrogen Whole Exome Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Macrogen Whole Exome Sequencing Product Portfolio Table 79. Macrogen Recent Development Table 80. BGI Company Information Table 81. BGI Business Overview Table 82. BGI Whole Exome Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. BGI Whole Exome Sequencing Product Portfolio Table 84. BGI Recent Development Table 85. Novo Gene Company Information Table 86. Novo Gene Business Overview Table 87. Novo Gene Whole Exome Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Novo Gene Whole Exome Sequencing Product Portfolio Table 89. Novo Gene Recent Development Table 90. North America Whole Exome Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 91. North America Whole Exome Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 92. North America Whole Exome Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 93. North America Whole Exome Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 94. North America Whole Exome Sequencing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America Whole Exome Sequencing Revenue by Country (2021-2026) & (US$ Million) Table 96. North America Whole Exome Sequencing Revenue by Country (US$ Million) & (2027-2032) Table 97. Europe Whole Exome Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 98. Europe Whole Exome Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 99. Europe Whole Exome Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 100. Europe Whole Exome Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 101. Europe Whole Exome Sequencing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. Europe Whole Exome Sequencing Revenue by Country (2021-2026) & (US$ Million) Table 103. Europe Whole Exome Sequencing Revenue by Country (US$ Million) & (2027-2032) Table 104. China Whole Exome Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 105. China Whole Exome Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 106. China Whole Exome Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 107. China Whole Exome Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 108. Asia Whole Exome Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 109. Asia Whole Exome Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 110. Asia Whole Exome Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 111. Asia Whole Exome Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 112. Asia Whole Exome Sequencing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Asia Whole Exome Sequencing Revenue by Region (US$ Million) & (2021-2026) Table 114. Asia Whole Exome Sequencing Revenue by Region (US$ Million) & (2027-2032) Table 115. SAMEA Whole Exome Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 116. SAMEA Whole Exome Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 117. SAMEA Whole Exome Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 118. SAMEA Whole Exome Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 119. SAMEA Whole Exome Sequencing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. SAMEA Whole Exome Sequencing Revenue by Country (2021-2026) & (US$ Million) Table 121. SAMEA Whole Exome Sequencing Revenue by Country (US$ Million) & (2027-2032) Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Whole Exome Sequencing Image Figure 2. Global Whole Exome Sequencing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Whole Exome Sequencing Market Size Share 2021 VS 2025 VS 2032 Figure 4. Agilent HaloPlex Image Figure 5. Agilent SureSelect Image Figure 6. Agilent SureSelect QXT Image Figure 7. Illumina TruSeq Exome Image Figure 8. Roche Nimblegen SeqCap Image Figure 9. MYcroarray MYbaits Image Figure 10. Global Whole Exome Sequencing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Whole Exome Sequencing Market Size Share 2021 VS 2025 VS 2032 Figure 12. Correlation Research of Normal Human Image Figure 13. Mendelian Disease and Rare Syndrome Gene Discovery Image Figure 14. The Research of Complex Diseases Image Figure 15. Mouse Exome Sequencing Image Figure 16. Global Whole Exome Sequencing Market Size (US$ Million) & (2021-2032) Figure 17. Global Whole Exome Sequencing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Whole Exome Sequencing Market Share by Region: 2021 VS 2025 VS 2032 Figure 19. Global Whole Exome Sequencing Players Revenue Share Top 10 and Top 5 in 2025 Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Whole Exome Sequencing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Whole Exome Sequencing Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Whole Exome Sequencing Revenue Market Share by Type (2021-2032) Figure 24. Global Whole Exome Sequencing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Whole Exome Sequencing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 26. Global Whole Exome Sequencing Revenue Market Share by Application (2021-2032) Figure 27. North America Whole Exome Sequencing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 28. North America Whole Exome Sequencing Revenue Share by Type (2021-2032) Figure 29. North America Whole Exome Sequencing Revenue Share by Application (2021-2032) Figure 30. North America Whole Exome Sequencing Revenue Share by Country (2021-2032) Figure 31. United States Whole Exome Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Canada Whole Exome Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Mexico Whole Exome Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Europe Whole Exome Sequencing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 35. Europe Whole Exome Sequencing Revenue Share by Type (2021-2032) Figure 36. Europe Whole Exome Sequencing Revenue Share by Application (2021-2032) Figure 37. Europe Whole Exome Sequencing Revenue Share by Country (2021-2032) Figure 38. Germany Whole Exome Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. France Whole Exome Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. U.K. Whole Exome Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Italy Whole Exome Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Spain Whole Exome Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Russia Whole Exome Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Netherlands Whole Exome Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Nordic Countries Whole Exome Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. China Whole Exome Sequencing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. China Whole Exome Sequencing Revenue Share by Type (2021-2032) Figure 48. China Whole Exome Sequencing Revenue Share by Application (2021-2032) Figure 49. Asia Whole Exome Sequencing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 50. Asia Whole Exome Sequencing Revenue Share by Type (2021-2032) Figure 51. Asia Whole Exome Sequencing Revenue Share by Application (2021-2032) Figure 52. Asia Whole Exome Sequencing Revenue Share by Region (2021-2032) Figure 53. Japan Whole Exome Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. South Korea Whole Exome Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. India Whole Exome Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Australia Whole Exome Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Taiwan Whole Exome Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Southeast Asia Whole Exome Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. SAMEA Whole Exome Sequencing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 60. SAMEA Whole Exome Sequencing Revenue Share by Type (2021-2032) Figure 61. SAMEA Whole Exome Sequencing Revenue Share by Application (2021-2032) Figure 62. SAMEA Whole Exome Sequencing Revenue Share by Country (2021-2032) Figure 63. Brazil Whole Exome Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Argentina Whole Exome Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Chile Whole Exome Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Colombia Whole Exome Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Peru Whole Exome Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Saudi Arabia Whole Exome Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Israel Whole Exome Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. UAE Whole Exome Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Turkey Whole Exome Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Iran Whole Exome Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Egypt Whole Exome Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Agilent HaloPlex
  • Agilent SureSelect
  • Agilent SureSelect QXT
  • Illumina TruSeq Exome
  • Roche Nimblegen SeqCap
  • MYcroarray MYbaits
Applications
  • Correlation Research of Normal Human
  • Mendelian Disease and Rare Syndrome Gene Discovery
  • The Research of Complex Diseases
  • Mouse Exome Sequencing
Companies covered
  • Illumina
  • Thermo Fisher
  • Roche
  • Angilent
  • Eurofins
  • Sengenics
  • Ambry
  • Macrogen
  • BGI
  • Novo Gene

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Whole Exome Sequencing Market by Type
  3. 1.2.1 Global Whole Exome Sequencing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Agilent HaloPlex
  5. 1.2.3 Agilent SureSelect
  6. 1.2.4 Agilent SureSelect QXT
  7. 1.2.5 Illumina TruSeq Exome
  8. 1.2.6 Roche Nimblegen SeqCap
  9. 1.2.7 MYcroarray MYbaits
  10. 1.3 Whole Exome Sequencing Market by Application
  11. 1.3.1 Global Whole Exome Sequencing Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Correlation Research of Normal Human
  13. 1.3.3 Mendelian Disease and Rare Syndrome Gene Discovery
  14. 1.3.4 The Research of Complex Diseases
  15. 1.3.5 Mouse Exome Sequencing
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Whole Exome Sequencing Market Dynamics
  1. 2.1 Whole Exome Sequencing Industry Trends
  2. 2.2 Whole Exome Sequencing Industry Drivers
  3. 2.3 Whole Exome Sequencing Industry Opportunities and Challenges
  4. 2.4 Whole Exome Sequencing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Whole Exome Sequencing Market Perspective (2021-2032)
  2. 3.2 Global Whole Exome Sequencing Growth Trends by Region
  3. 3.2.1 Global Whole Exome Sequencing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Whole Exome Sequencing Market Size by Region (2021-2026)
  5. 3.2.3 Global Whole Exome Sequencing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Whole Exome Sequencing Revenue by Players
  2. 4.1.1 Global Whole Exome Sequencing Revenue by Players (2021-2026)
  3. 4.1.2 Global Whole Exome Sequencing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Whole Exome Sequencing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Whole Exome Sequencing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Whole Exome Sequencing Key Players Headquarters & Area Served
  7. 4.4 Global Whole Exome Sequencing Players, Product Type & Application
  8. 4.5 Global Whole Exome Sequencing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Whole Exome Sequencing Market CR5 and HHI
  11. 4.6.3 2025 Whole Exome Sequencing Tier 1, Tier 2, and Tier 3
5 Whole Exome Sequencing Market Size by Type
  1. 5.1 Global Whole Exome Sequencing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Whole Exome Sequencing Revenue by Type (2021-2032)
  3. 5.3 Global Whole Exome Sequencing Revenue Market Share by Type (2021-2032)
6 Whole Exome Sequencing Market Size by Application
  1. 6.1 Global Whole Exome Sequencing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Whole Exome Sequencing Revenue by Application (2021-2032)
  3. 6.3 Global Whole Exome Sequencing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Illumina
  2. 7.1.1 Illumina Company Information
  3. 7.1.2 Illumina Business Overview
  4. 7.1.3 Illumina Whole Exome Sequencing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Illumina Whole Exome Sequencing Product Portfolio
  6. 7.1.5 Illumina Recent Developments
  7. 7.2 Thermo Fisher
  8. 7.2.1 Thermo Fisher Company Information
  9. 7.2.2 Thermo Fisher Business Overview
  10. 7.2.3 Thermo Fisher Whole Exome Sequencing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Thermo Fisher Whole Exome Sequencing Product Portfolio
  12. 7.2.5 Thermo Fisher Recent Developments
  13. 7.3 Roche
  14. 7.3.1 Roche Company Information
  15. 7.3.2 Roche Business Overview
  16. 7.3.3 Roche Whole Exome Sequencing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Roche Whole Exome Sequencing Product Portfolio
  18. 7.3.5 Roche Recent Developments
  19. 7.4 Angilent
  20. 7.4.1 Angilent Company Information
  21. 7.4.2 Angilent Business Overview
  22. 7.4.3 Angilent Whole Exome Sequencing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Angilent Whole Exome Sequencing Product Portfolio
  24. 7.4.5 Angilent Recent Developments
  25. 7.5 Eurofins
  26. 7.5.1 Eurofins Company Information
  27. 7.5.2 Eurofins Business Overview
  28. 7.5.3 Eurofins Whole Exome Sequencing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Eurofins Whole Exome Sequencing Product Portfolio
  30. 7.5.5 Eurofins Recent Developments
  31. 7.6 Sengenics
  32. 7.6.1 Sengenics Company Information
  33. 7.6.2 Sengenics Business Overview
  34. 7.6.3 Sengenics Whole Exome Sequencing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Sengenics Whole Exome Sequencing Product Portfolio
  36. 7.6.5 Sengenics Recent Developments
  37. 7.7 Ambry
  38. 7.7.1 Ambry Company Information
  39. 7.7.2 Ambry Business Overview
  40. 7.7.3 Ambry Whole Exome Sequencing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Ambry Whole Exome Sequencing Product Portfolio
  42. 7.7.5 Ambry Recent Developments
  43. 7.8 Macrogen
  44. 7.8.1 Macrogen Company Information
  45. 7.8.2 Macrogen Business Overview
  46. 7.8.3 Macrogen Whole Exome Sequencing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Macrogen Whole Exome Sequencing Product Portfolio
  48. 7.8.5 Macrogen Recent Developments
  49. 7.9 BGI
  50. 7.9.1 BGI Company Information
  51. 7.9.2 BGI Business Overview
  52. 7.9.3 BGI Whole Exome Sequencing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 BGI Whole Exome Sequencing Product Portfolio
  54. 7.9.5 BGI Recent Developments
  55. 7.10 Novo Gene
  56. 7.10.1 Novo Gene Company Information
  57. 7.10.2 Novo Gene Business Overview
  58. 7.10.3 Novo Gene Whole Exome Sequencing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Novo Gene Whole Exome Sequencing Product Portfolio
  60. 7.10.5 Novo Gene Recent Developments
8 North America
  1. 8.1 North America Whole Exome Sequencing Revenue (2021-2032)
  2. 8.2 North America Whole Exome Sequencing Revenue by Type (2021-2032)
  3. 8.2.1 North America Whole Exome Sequencing Revenue by Type (2021-2026)
  4. 8.2.2 North America Whole Exome Sequencing Revenue by Type (2027-2032)
  5. 8.3 North America Whole Exome Sequencing Revenue Share by Type (2021-2032)
  6. 8.4 North America Whole Exome Sequencing Revenue by Application (2021-2032)
  7. 8.4.1 North America Whole Exome Sequencing Revenue by Application (2021-2026)
  8. 8.4.2 North America Whole Exome Sequencing Revenue by Application (2027-2032)
  9. 8.5 North America Whole Exome Sequencing Revenue Share by Application (2021-2032)
  10. 8.6 North America Whole Exome Sequencing Revenue by Country
  11. 8.6.1 North America Whole Exome Sequencing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Whole Exome Sequencing Revenue by Country (2021-2026)
  13. 8.6.3 North America Whole Exome Sequencing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Whole Exome Sequencing Revenue (2021-2032)
  2. 9.2 Europe Whole Exome Sequencing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Whole Exome Sequencing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Whole Exome Sequencing Revenue by Type (2027-2032)
  5. 9.3 Europe Whole Exome Sequencing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Whole Exome Sequencing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Whole Exome Sequencing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Whole Exome Sequencing Revenue by Application (2027-2032)
  9. 9.5 Europe Whole Exome Sequencing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Whole Exome Sequencing Revenue by Country
  11. 9.6.1 Europe Whole Exome Sequencing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Whole Exome Sequencing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Whole Exome Sequencing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Whole Exome Sequencing Revenue (2021-2032)
  2. 10.2 China Whole Exome Sequencing Revenue by Type (2021-2032)
  3. 10.2.1 China Whole Exome Sequencing Revenue by Type (2021-2026)
  4. 10.2.2 China Whole Exome Sequencing Revenue by Type (2027-2032)
  5. 10.3 China Whole Exome Sequencing Revenue Share by Type (2021-2032)
  6. 10.4 China Whole Exome Sequencing Revenue by Application (2021-2032)
  7. 10.4.1 China Whole Exome Sequencing Revenue by Application (2021-2026)
  8. 10.4.2 China Whole Exome Sequencing Revenue by Application (2027-2032)
  9. 10.5 China Whole Exome Sequencing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Whole Exome Sequencing Revenue (2021-2032)
  2. 11.2 Asia Whole Exome Sequencing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Whole Exome Sequencing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Whole Exome Sequencing Revenue by Type (2027-2032)
  5. 11.3 Asia Whole Exome Sequencing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Whole Exome Sequencing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Whole Exome Sequencing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Whole Exome Sequencing Revenue by Application (2027-2032)
  9. 11.5 Asia Whole Exome Sequencing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Whole Exome Sequencing Revenue by Country
  11. 11.6.1 Asia Whole Exome Sequencing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Whole Exome Sequencing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Whole Exome Sequencing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Whole Exome Sequencing Revenue (2021-2032)
  2. 12.2 SAMEA Whole Exome Sequencing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Whole Exome Sequencing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Whole Exome Sequencing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Whole Exome Sequencing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Whole Exome Sequencing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Whole Exome Sequencing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Whole Exome Sequencing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Whole Exome Sequencing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Whole Exome Sequencing Revenue by Country
  11. 12.6.1 SAMEA Whole Exome Sequencing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Whole Exome Sequencing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Whole Exome Sequencing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst